1 138 124 A PRELIMINARY REPORT ON THE ROLE OF YOGA ASANAS ON OXIDATIVE STRESS IN NON-INSULIN DEPENDENT DIABETES MELLITUS. NINETEEN SUBJECTS OF NON-INSULIN DEPENDENT DIABETES MELLITUS (NIDDM) BETWEEN THE AGE GROUP OF 30-60 YRS WERE STUDIED TO SEE THE EFFECT OF SPECIFIC YOGA ASANAS ON FASTING AND POSTPRANDIAL BLOOD GLUCOSE (FBG, PPG), SERUM MALONDIALDEHYDE (MDA) AND GLYCOSYLATED HEMOGLOBIN (HBA(1)) IN ADDITION TO DRUG TREATMENT AND DIET CONTROL. THE DURATION OF DIABETES RANGED FROM 1-10 YEARS. PATIENTS WITH RENAL, CARDIAC AND PROLIFERATIVE RETINAL DISEASES WERE EXCLUDED FROM THE STUDY. THE SAME PATIENTS SERVED AS THEIR OWN CONTROL. SUBJECTS WERE CALLED IN THE MORNING TO THE CARDIO-RESPIRATORY LABORATORY AND WERE GIVEN TRAINING BY A YOGA EXPERT. YOGA ASANAS INCLUDED SURYANAMSKAR, TADASAN, TRIKONASAN, PADMASAN, PRANAYAM, PASCHIMOTTANASAN, ARDHMATSYENDRASAN, PAVANMUKTHASAN, SARPASAN AND SHAVASAN. THE ASANAS WERE DONE EVERY DAY FOR 40 DAYS FOR 30-40 MIN. FBG, PPG, SERUM MDA AND HBA(1) WERE ESTIMATED BEFORE AND AFTER 40 DAYS OF YOGA ASANAS REGIMEN. SIGNIFICANT REDUCTION WAS SEEN IN FBG FROM 220 MG/DL TO 162 MG/DL, PPG FROM 311 MG/DL TO 255 MG/DL, MDA FROM 6 NMOL/L TO 3 NMOL/L AND HBA(1), FROM 8.8% TO 6.4%. SUBJECTS FELT BETTER AND WERE RELIEVED OF THEIR STRESSES AND HAD AN IMPROVEMENT IN THEIR DAY TO DAY PERFORMANCE. THE DECREASE WAS STATISTICALLY SIGNIFICANT (P<0.0001 FOR FBG AND PPG, P<0.001 FOR MDA AND FOR HBA(1)). 2001 2 2056 48 THE BENEFICIAL EFFECT OF YOGA IN DIABETES. TWENTY NIDDM SUBJECTS (MILD TO MODERATE DIABETICS) IN THE AGE GROUP OF 30-60 YEARS WERE SELECTED FROM THE OUT PATIENT CLINIC OF G.T.B. HOSPITAL. THEY WERE ON A 40 DAYS YOGA ASANA REGIME UNDER THE SUPERVISION OF A YOGA EXPERT. 13 SPECIFIC YOGA ASANAS < OR = DONE BY TYPE 2 DIABETES PATIENTS INCLUDED. SURYA NAMASKAR, TRIKONASANA, TADASANA, SUKHASANA, PADMASANA, BHASTRIKA PRANAYAMA, PASHIMOTTANASANA, ARDHMATSYENDRASANA, PAWANMUKTASANA, BHUJANGASANA, VAJRASANA, DHANURASANA AND SHAVASANA ARE BENEFICIAL FOR DIABETES MELLITUS. SERUM INSULIN, PLASMA FASTING AND ONE HOUR POSTPRANDIAL BLOOD GLUCOSE LEVELS AND ANTHROPOMETRIC PARAMETERS WERE MEASURED BEFORE AND AFTER YOGA ASANAS. THE RESULTS INDICATE THAT THERE WAS SIGNIFICANT DECREASE IN FASTING GLUCOSE LEVELS FROM BASAL 208.3 +/- 20.0 TO 171.7 +/- 19.5 MG/DL AND ONE HOUR POSTPRANDIAL BLOOD GLUCOSE LEVELS DECREASED FROM 295.3 +/- 22.0 TO 269.7 +/- 19.9 MG/DL. THE EXACT MECHANISM AS TO HOW THESE POSTURES AND CONTROLLED BREATHING INTERACT WITH SOMATOENDOCRINE MECHANISM AFFECTING INSULIN KINETICS WAS WORKED OUT. A SIGNIFICANT DECREASE IN WAIST-HIP RATIO AND CHANGES IN INSULIN LEVELS WERE ALSO OBSERVED, SUGGESTING A POSITIVE EFFECT OF YOGA ASANAS ON GLUCOSE UTILISATION AND FAT REDISTRIBUTION IN NIDDM. YOGA ASANAS MAY BE USED AS AN ADJUNCT WITH DIET AND DRUGS IN THE MANAGEMENT OF TYPE 2 DIABETES. 2005 3 2007 40 STUDY OF YOGA ASANAS IN ASSESSMENT OF PULMONARY FUNCTION IN NIDDM PATIENTS. CERTAIN YOGA ASANAS IF PRACTICED REGULARLY ARE KNOWN TO HAVE BENEFICIAL EFFECTS ON HUMAN BODY. THESE YOGA PRACTICES MIGHT BE INTERACTING WITH VARIOUS, SOMATO-NEURO-ENDOCRINE MECHANISMS TO HAVE THERAPEUTIC EFFECTS. THE PRESENT STUDY DONE IN TWENTY FOUR NIDDM PATIENTS OF 30 TO 60 YEAR OLD, PROVIDES METABOLIC AND CLINICAL EVIDENCE OF IMPROVEMENT IN GLYCAEMIC CONTROL AND PULMONARY FUNCTIONS. THESE MIDDLE-AGED SUBJECTS WERE TYPE II DIABETICS ON ANTIHYPERGLYCAEMIC AND DIETARY REGIMEN. THEIR BASELINE FASTING AND POSTPRANDIAL BLOOD GLUCOSE AND GLYCOSYLATED HB WERE MONITORED ALONG WITH PULMONARY FUNCTION STUDIES. THE EXPERT GAVE THESE PATIENTS TRAINING IN YOGA ASANAS AND WERE PURSED 30-40 MIN/DAY FOR 40 DAYS UNDER GUIDANCE. THESE ASANAS CONSISTED OF 13 WELL KNOWN POSTURES, DONE IN A SEQUENCE. AFTER 40 DAYS OF YOGA ASANAS REGIMEN, THE PARAMETERS WERE REPEATED. THE RESULTS INDICATE THAT THERE WAS SIGNIFICANT DECREASE IN FASTING BLOOD GLUCOSE LEVELS (BASAL 190.08 +/- 90.8 IN MG/DL TO 141.5 +/- 79.8 IN MG/DL). THE POSTPRANDIAL BLOOD GLUCOSE LEVELS ALSO DECREASED (276.54 +/- 101.0 IN MG/DL TO 201.75 +/- 104.1 IN MG/DL), GLYCOSYLATED HEMOGLOBIN SHOWED A DECREASE (9.03 +/- 1.4% TO 7.83 +/- 2.6%). THE FEV1, FVC, PEFR, MVV INCREASED SIGNIFICANTLY (1.81 +/- 0.4 LT TO 2.08 +/- 0.4 LT, 2.20 +/- 0.6 LT TO 2.37 +/- 0.5 LT, 3.30 +/- 1.0 LT/S TO 4.43 +/- 1.4 LT/S AND 64.59 +/- 25.7 LT MIN TO 76.28 +/- 28.1 LT/MIN RESPECTIVELY). FEV1/FVC% IMPROVED (85 +/- 0.2% TO 89 +/- 0.1%). THESE FINDINGS SUGGEST THAT BETTER GLYCAEMIC CONTROL AND PULMONARY FUNCTIONS CAN BE OBTAINED IN NIDDM CASES WITH YOGA ASANAS AND PRANAYAMA. THE EXACT MECHANISM AS TO HOW THESE POSTURES AND CONTROLLED BREATHING, INTERACT WITH SOMATO-NEURO-ENDOCRINE MECHANISM AFFECTING METABOLIC AND PULMONARY FUNCTIONS REMAINS TO BE WORKED OUT. 2002 4 1933 42 ROLE OF YOGA IN MODIFYING CERTAIN CARDIOVASCULAR FUNCTIONS IN TYPE 2 DIABETIC PATIENTS. OBJECTIVES: 1. TO STUDY THE EFFECT OF FORTY DAYS OF YOGIC EXERCISES ON CARDIAC FUNCTIONS IN TYPE 2 DIABETICS. 2. TO STUDY THE EFFECT OF FORTY DAYS OF YOGIC EXERCISES ON BLOOD GLUCOSE LEVEL, GLYCOSYLATED HEMOGLOBIN. METHODS: THE PRESENT STUDY DONE IN TWENTY-FOUR TYPE 2 DM CASES PROVIDES METABOLIC AND CLINICAL EVIDENCE OF IMPROVEMENT IN GLYCAEMIC CONTROL AND AUTONOMIC FUNCTIONS. THESE MIDDLE-AGED SUBJECTS WERE TYPE II DIABETICS ON ANTIHYPERGLYCAEMIC AND DIETARY REGIMEN. THEIR BASELINE FASTING AND POSTPRANDIAL BLOOD GLUCOSE AND GLYCOSYLATED HB WERE MONITORED ALONG WITH AUTONOMIC FUNCTION STUDIES. THE EXPERT GAVE THESE PATIENTS TRAINING IN YOGA ASANAS AND THEY PURSUED THOSE 30-40 MIN/DAY FOR 40 DAYS UNDER GUIDANCE. THESE ASANAS CONSISTED OF 13 WELL KNOWN POSTURES, DONE IN A SEQUENCE. AFTER 40 DAYS OF YOGA ASANAS REGIMEN, THE PARAMETERS WERE REPEATED. RESULTS: THE RESULTS INDICATE THAT THERE WAS SIGNIFICANT DECREASE IN FASTING BLOOD GLUCOSE LEVELS FROM BASAL 190.08 +/- 18.54 IN MG/DL TO 141.5 +/- 16.3 IN MG/DL AFTER YOGA REGIMEN. THE POST PRANDIAL BLOOD GLUCOSE LEVELS DECREASED FROM 276.54 +/- 20.62 IN MG/DL TO 201.75 +/- 21.24 IN MG/DL, GLYCOSYLATED HEMOGLOBIN SHOWED A DECREASE FROM 9.03 +/- 0.29% TO 7.83 +/- 0.53% AFTER YOGA REGIMEN. THE PULSE RATE, SYSTOLIC AND DIASTOLIC BLOOD PRESSURE DECREASED SIGNIFICANTLY (FROM 86.45 +/- 2.0 TO 77.65 +/- 2.5 PULSE/MIN, FROM 142.0 +/- 3.9 TO 126.0 +/- 3.2 MM OF HG AND FROM 86.7 +/- 2.5 MM OF HG TO 75.5 +/- 2.1 MM OF HG AFTER YOGA REGIMEN RESPECTIVELY). CORRECTED QT INTERVAL (QTC) DECREASED FROM 0.42 +/- 0.0 TO 0.40 +/- 0.0. CONCLUSION: THESE FINDINGS SUGGEST THAT BETTER GLYCAEMIC CONTROL AND STABLE AUTONOMIC FUNCTIONS CAN BE OBTAINED IN TYPE 2 DM CASES WITH YOGA ASANAS AND PRANAYAMA. THE EXACT MECHANISM AS TO HOW THESE POSTURES AND CONTROLLED BREATHING INTERACT WITH SOMATO-NEURO-ENDOCRINE MECHANISM AFFECTING METABOLIC AND AUTONOMIC FUNCTIONS REMAINS TO BE WORKED OUT. 2004 5 781 61 EFFECT OF YOGA ASANAS ON NERVE CONDUCTION IN TYPE 2 DIABETES. TWENTY TYPE 2 DIABETIC SUBJECTS BETWEEN THE AGE GROUP OF 30-60 YEARS WERE STUDIED TO SEE THE EFFECT OF 40 DAYS OF YOGA ASANAS ON THE NERVE CONDUCTION VELOCITY. THE DURATION OF DIABETES RANGED FROM 0-10 YEARS. SUBJECT SUFFERING FROM CARDIAC, RENAL AND PROLIFERATIVE RETINAL COMPLICATIONS WERE EXCLUDED FROM THE STUDY YOGA ASANAS INCLUDED SURYANAMSKAR. TADASAN, KONASAN, PADMASAN PRANAYAM, PASCHIMOTTANSAN ARDHMATSYENDRASAN, SHAVASAN, PAVANMUKTHASAN, SARPASAN AND SHAVASAN. SUBJECTS WERE CALLED TO THE CARDIO-RESPIRATORY LABORATORY IN THE MORNING TIME AND WERE GIVEN TRAINING BY THE YOGA EXPERT. THE YOGA EXERCISES WERE PERFORMED FOR 30-40 MINUTES EVERY DAY FOR 40 DAYS IN THE ABOVE SEQUENCE. THE SUBJECTS WERE PRESCRIBED CERTAIN MEDICINES AND DIET. THE BASAL BLOOD GLUCOSE, NERVE CONDUCTION VELOCITY OF THE MEDIAN NERVE WAS MEASURED AND REPEATED AFTER 40 DAYS OF YOGIC REGIME. ANOTHER GROUP OF 20 TYPE 2 DIABETES SUBJECTS OF COMPARABLE AGE AND SEVERITY, CALLED THE CONTROL GROUP, WERE KEPT ON PRESCRIBED MEDICATION AND LIGHT PHYSICAL EXERCISES LIKE WALKING. THEIR BASAL & POST 40 DAYS PARAMETERS WERE RECORDED FOR COMPARISON. RIGHT HAND AND LEFT HAND MEDIAN NERVE CONDUCTION VELOCITY INCREASED FROM 52.81 +/- 1.1 M/SEC TO 53.87 +/- 1.1 M/SEC AND 52.46 +/- 1.0 TO 54.75 +/- 1/1 M/SEC RESPECTIVELY. CONTROL GROUP NERVE FUNCTION PARAMETERS DETERIORATED OVER THE PERIOD OF STUDY, INDICATING THAT DIABETES IS A SLOWLY PROGRESSIVE DISEASE INVOLVING THE NERVES. YOGA ASANAS HAVE A BENEFICIAL EFFECT ON GLYCAEMIC CONTROL AND IMPROVE NERVE FUNCTION IN MILD TO MODERATE TYPE 2 DIABETES WITH SUB-CLINICAL NEUROPATHY. 2002 6 213 27 A STUDY OF RESPONSE PATTERN OF NON-INSULIN DEPENDENT DIABETICS TO YOGA THERAPY. CHANGES IN BLOOD GLUCOSE AND GLUCOSE TOLERANCE BY ORAL GLUCOSE TOLERANCE TEST (OGTT) AFTER 40 DAYS OF YOGA THERAPY IN 149 NON-INSULIN-DEPENDENT DIABETICS (NIDDM) WERE INVESTIGATED. THE RESPONSE TO YOGA IN THESE SUBJECTS WAS CATEGORIZED ACCORDING TO A SEVERITY SCALE INDEX (SSI) BASED ON AREA INDEX TOTAL (AIT) UNDER OGTT CURVE. ONE HUNDRED AND FOUR PATIENTS SHOWED A FAIR TO GOOD RESPONSE TO THE YOGA THERAPY. THERE WAS A SIGNIFICANT REDUCTION IN HYPERGLYCEMIA AND AIT WITH DECREASE IN ORAL HYPOGLYCEMIA AND AIT WITH DECREASE IN ORAL HYPOGLYCEMIC DRUGS REQUIRED FOR MAINTENANCE OF NORMOGLYCEMIA. IT IS CONCLUDED THAT YOGA, A SIMPLE AND ECONOMICAL THERAPY, MAY BE CONSIDERED A BENEFICIAL ADJUVANT FOR NIDDM PATIENTS. 1993 7 2885 38 YOGA: AS AN ADJUNCT THERAPY TO TRIM DOWN THE AYURVEDIC DRUG REQUIREMENT IN NON INSULIN-DEPENDENT DIABETES MELLITUS. INTRODUCTION: IN SPITE OF A LARGE NUMBER OF DRUGS SHOWING ANTI-HYPERGLYCEMIC ACTIVITIES, NONE OF THEM HAVE BEEN SUCCESSFUL IN COMPLETE MANAGEMENT OF DIABETES MELLITUS (DM). YOGA AND AYURVEDA ARE THE TWO SCHOOLS OF THOUGHT IN INDIA, WHICH HAVE A HISTORY OF CURING DISEASES SINCE THOUSANDS OF YEARS. YOGIC TECHNIQUES AND AYURVEDIC HERBS HAVE PROVEN THEIR ANTI-DIABETIC POTENTIAL WITHOUT INDUCING UNTOWARD EFFECTS. THE PRESENT STUDY COMBINES AYURVEDIC MEDICATION WITH YOGA TECHNIQUES AS A NEW APPROACH TOWARD HEALING DM. AIMS AND OBJECTIVES: TO ASSESS THE EFFECT OF YOGA THERAPY IN THE MANAGEMENT OF NON INSULIN-DEPENDENT DM (NIDDM) AND TO DECREASE THE ORAL DRUG DOSE REQUIREMENT OF GUDUCI GHANA TABLET. MATERIALS AND METHODS: THIRTY KNOWN NIDDM PATIENTS OF BOTH GENDERS, WHO WERE ON GUDUCI GHANA (SOLIDIFIED AQUEOUS EXTRACT OF TINOSPORA CORDIFOLIA (WILLD.) MIERS.) TABLETS FROM PAST 2 MONTHS AS AYURVEDIC REMEDY FOR DM WERE SELECTED. ALONG WITH GUDUCI GHANA ADMINISTRATION, THE SUBJECTS WERE INSTRUCTED TO FOLLOW YOGIC PROCEDURES INCLUDING ASANAS, PRANAYAMA, AND SUDDHI KRIYAS. THE STUDY WAS CONDUCTED FOR 8 WEEKS, WHEREIN FASTING BLOOD SUGAR (FBS) AND POSTPRANDIAL BLOOD SUGAR (PPBS) LEVELS ALONG WITH RELIEF IN SIGN AND SYMPTOMS WERE ASSESSED AT EVERY 2 WEEKS INTERVALS, AND ACCORDING TO RELIEF IN SIGN AND SYMPTOMS, TAPERING OF DRUG DOSAGE WAS CARRIED OUT. THE OBTAINED DATA WERE ANALYZED STATISTICALLY BY APPLYING PAIRED T-TEST. RESULTS AND CONCLUSION: THE RESULTS OBTAINED WERE PROMISING AS THE RELIEF IN DIABETIC SYMPTOMATOLOGY WAS HIGHLY SIGNIFICANT IN TERMS OF P VALUE. 80.83% REDUCTION IN DOSE OF GUDUCI GHANA TABLETS AND 7.85% AND 8.78% FALL IN FBS AND PPBS LEVELS, RESPECTIVELY, AFTER THE COMPLETE COURSE OF TREATMENT. THE OBTAINED P VALUE SHOWED HIGHLY SIGNIFICANT RESULTS. 2014 8 895 33 EFFECT OF YOGA-NIDRA ON BLOOD GLUCOSE LEVEL IN DIABETIC PATIENTS. DIABETES IS A METABOLIC DISORDER, WHICH HAS BECOME A MAJOR HEALTH CHALLENGE WORLDWIDE. SOUTH EAST ASIAN COUNTRIES HAVE A HIGHEST BURDEN OF DIABETES. IN INDIA THE PREVALENCE OF DIABETES IS RISING RAPIDLY ESPECIALLY IN THE URBAN POPULATION BECAUSE OF INCREASING OBESITY AND REDUCED PHYSICAL ACTIVITY. AN OBJECTIVE OF THIS STUDY IS TO EVALUATE THE EFFECT OF YOGA-NIDRA ON BLOOD GLUCOSE LEVEL IN DIABETIC PATIENTS. THIS STUDY WAS CONDUCTED ON 41, MIDDLE AGED, TYPE-2 DIABETIC PATIENTS, WHO WERE ON ORAL HYPOGLYCAEMIC. THESE PATIENTS WERE DIVIDED IN TO TWO GROUPS: (A) 20 PATIENTS ON ORAL HYPOGLYCAEMIC WITH YOGA-NIDRA, AND (B) 21 WERE ON ORAL HYPOGLYCAEMIC ALONE. YOGA-NIDRA PRACTICED FOR 30 MINUTES DAILY UP TO 90 DAYS, PARAMETERS WERE RECORDED EVERY. 30TH DAY. RESULTS OF THIS STUDY SHOWED THAT MOST OF THE SYMPTOMS WERE SUBSIDED (P < 0.004, SIGNIFICANT), AND FALL OF MEAN BLOOD GLUCOSE LEVEL WAS SIGNIFICANT AFTER 3-MONTH OF YOGA-NIDRA. THIS FALL WAS 21.3 MG/DL, P < 0.0007, (FROM 159 +/- 12.27 TO 137.7 +/- 23.15,) IN FASTING AND 17.95 MG/DL, P = 0.02, (FROM 255.45 +/- 16.85 TO 237.5 +/- 30.54) IN POST PRANDIAL GLUCOSE LEVEL. RESULTS OF THIS STUDY SUGGEST THAT SUBJECTS ON YOGA-NIDRA WITH DRUG REGIMEN HAD BETTER CONTROL IN THEIR FLUCTUATING BLOOD GLUCOSE AND SYMPTOMS ASSOCIATED WITH DIABETES, COMPARED TO THOSE WERE ON ORAL HYPOGLYCAEMICS ALONE. 2009 9 839 26 EFFECT OF YOGA ON PLASMA GLUCOSE, LIPID PROFILE, BLOOD PRESSURE AND INSULIN REQUIREMENT IN A PATIENT WITH TYPE 1 DIABETES MELLITUS. OBJECTIVES: THE OBJECTIVE OF THE STUDY IS TO EVALUATE THE SHORT-TERM EFFECT OF YOGA ON PLASMA GLUCOSE, LIPID PROFILE, BLOOD PRESSURE AND INSULIN REQUIREMENT IN A PATIENT WITH TYPE 1 DIABETES MELLITUS (T1DM). CASE PRESENTATION: A 28-YEARS OLD FEMALE WAS DIAGNOSED WITH T1DM AT THE AGE OF SEVEN. SHE WAS UNDER HUMAN MIXTARD INSULIN 30-70, THRICE/DAY FOR 15-15-15 UNITS. SHE HAD A HISTORY OF POOR GLYCEMIC CONTROL, DIABETIC KETOACIDOSIS AND HYPOGLYCEMIC SHOCK. AT THE AGE OF 27, SHE GOT ADMITTED WITH COMPLAINTS OF GENERAL WEAKNESS, JOINTS STIFFNESS AND WEIGHT LOSS IN OUR HOLISTIC HEALTH CENTRE AND UNDERWENT TWO WEEKS OF YOGA. RESULTS SHOWED A BETTER REDUCTION IN THE PLASMA GLUCOSE LEVELS, LIPID PROFILE, BLOOD PRESSURE AND INSULIN DOSE AND AN INCREASE IN HEMOGLOBIN LEVELS WITH NO EPISODES OF HYPOGLYCEMIA AFTER YOGA. CONCLUSIONS: YOGA MIGHT BE CONSIDERED AS A SAFER AND EFFECTIVE ADJUVANT IN THE MANAGEMENT OF T1DM. 2021 10 1476 31 INTEGRATED YOGA AND NATUROPATHY MODULE IN MANAGEMENT OF METABOLIC SYNDROME: A CASE REPORT. A 50-YEAR-OLD MALE PARTICIPANT WITH SEDENTARY LIFESTYLE, DIAGNOSED WITH METABOLIC SYNDROME (METS) [OBESITY, TYPE-2 DIABETES MELLITUS, HYPERTENSION] AND HYPOTHYROIDISM SINCE 2013, WAS ADMINISTERED INTEGRATED YOGA AND NATUROPATHY (IYN) FOR 6 WEEKS AS A TAILOR MADE INDIVIDUALIZED PROTOCOL AT THE RESIDENTIAL INTEGRATIVE MEDICAL FACILITY IN BANGALORE BETWEEN OCTOBER AND NOVEMBER 2015. THE RESULTS SHOWED REDUCTION IN WEIGHT (97.9 KG TO 74.6 KG), BODY MASS INDEX (BMI) (35.1 KG/M(2) TO 27.86 KG/M(2)), TOTAL CHOLESTEROL (192 MG% TO 145 MG%), TRIGLYCERIDES (153 MG% TO 90 MG%), LOW DENSITY LIPOPROTEIN (LDL) (124 MG% TO 81 MG%), HIGH DENSITY LIPOPROTEIN (HDL) (40 MG% TO 46 MG%), FASTING BLOOD GLUCOSE (110 MG/DL TO 75 MG/DL), POSTPRANDIAL GLUCOSE (267 MG/DL TO 100 MG/DL), GLYCATED HEMOGLOBIN (HBA1C) (7.8%-7.1%), THYROID STIMULATING HORMONE (TSH) (6.90 MUIU/ML TO 3.052 MUIU/ML). FOLLOWING THE INTERVENTION, THE ANTI-HYPERTENSIVE, ORAL HYPOGLYCEMIC, THYROID RAISING AND ANALGESIC MEDICINES WERE NOT REQUIRED TO BE CONTINUED. HIS KNEE PAIN MINIMIZED ON DISCHARGE AS OBSERVED ON A VISUAL ANALOG SCALE. HE HAD AN IMPROVED FEELING OF WELLNESS AND OVERALL FUNCTIONAL HEALTH. ALL HIS PARAMETERS WERE WITHIN NORMAL RANGE AT THE 12-WEEKS FOLLOW-UP, AS HE HAD INCORPORATED THE LIFESTYLE PROGRAM INTO HIS DAILY ROUTINE. THIS CASE REPORT SUGGESTS THAT LIFESTYLE CHANGE BY INTEGRATION OF SPECIFIC NON-DRUG YOGA AND NATUROPATHIC INTERVENTION IS USEFUL IN THE MANAGEMENT OF METS. 2017 11 897 22 EFFECT OF YOGASANA PRACTICE ON SYSTOLIC TIME INTERVALS. THERAPEUTIC VALUES OF YOGA PRACTICES ARE WELL DOCUMENTED IN THE ANCIENT INDIAN LITERATURE. IN THIS STUDY AN ATTEMPT HAS BEEN MADE TO SEE THE EFFECT OF YOGASANA PRACTICE ON CARDIAC FUNCTIONS BY MEASURING SYSTOLIC TIME INTERVALS (STI). THE ASANAS STUDIED ARE SIRSASANA, SARVANGASANA, HALASANA, PASCHIMOTTANASANA AND BHUJANGASANA. FIVE HEALTHY YOGASANA PRACTITIONERS WHO WHERE PRACTICING REGULARLY FOR MORE THAN A YEAR WERE THE SUBJECTS. THE RESULT OF THE STUDY WAS STATISTICALLY ANALYZED AND PRESENTED SYSTEMATICALLY HERE. 1990 12 1925 25 ROLE OF YOGA IN ALIENATING THE MEMORY DECLINE AND FRONTAL LOBE METABOLITE CHANGES IN TYPE 2 DIABETES. RECENT RESEARCH STUDIES HAVE ESTABLISHED THE FACT, THAT GLYCOSYLATION IS CAUSING THE MEMORY DECLINE AND THIS IS FURTHER SUPPORTED BY THE ALTERATION OF BRAIN METABOLITE CONCENTRATIONS IN DIABETES. THE PRESENT STUDY IS HYPOTHESIZED THAT YOGA IS HAVING ALIENATING ABILITY OF MEMORY DECLINE AND ALTERATION OF FRONTAL LOBE METABOLITE CONCENTRATIONS, WHICH ARE THE RESULT OF GLYCOSYLATION IN TYPE 2 DIABETES. FIVE TYPE 2 DIABETIC SUBJECTS OF BOTH THE SEX, AGED BETWEEN 35-55 YEARS, WHO PRACTICED YOGA OVER A PERIOD OF SIX MONTHS IN A YOGA INSTITUTE, WERE RECRUITED AS TEST GROUP. AGE AND SEX MATCHED FIVE TYPE 2 DIABETIC SUBJECTS WERE RECRUITED AS CONTROL GROUP, BOTH THE GROUP SUBJECTS ARE ON ORAL HYPOGLYCAEMIC AGENTS. GLYCOSYLATED HAEMOGLOBIN PERCENTAGE WAS ESTIMATED WITH BIO-RAD INSTRUMENT, FRONTAL LOBE METABOLITES WERE ESTIMATED WITH PROTON MAGNETIC RESONANCE SPECTROSCOPY (H-MRS), MEMORY WAS CALCULATED WITH PGI-MEMORY SCALE (PGIMS) THAT IS A PART OF PGI-BATTERY OF BRAIN DYSFUNCTION (PGI-BBD), WHICH IS A NEUROPSYCHOLOGICAL BATTERY. MEAN GLYCOSYLATED HAEMOGLOBIN PERCENTAGE AND MEMORY DYSFUNCTION RATING IN CONTROL AND TEST GROUP SUBJECTS ARE 6.9+/-0.4 & 7.8+/-1.84 (P=0.03), AND 14+/-1& 6+/-1 (P=0.0001) RESPECTIVELY. RIGHT AND LEFT FRONTAL LOBE N-ACETYL ASPARTATE (NAA) AND MYOIONOSITOL (MI) CONCENTRATIONS WERE MORE OR LESS SIMILAR IN BOTH THE GROUPS. YOGA IS HAVING A SIGNIFICANT ROLE IN ALIENATING THE DECLINE IN MEMORY CAUSED BY GLYCOSYLATION IN TYPE 2 DIABETES BUT NOT ON THE ALTERATION OF FRONTAL LOBE NAA AND MI CONCENTRATIONS. 2016 13 1453 33 INFLUENCE OF PRANAYAMAS AND YOGA-ASANAS ON SERUM INSULIN, BLOOD GLUCOSE AND LIPID PROFILE IN TYPE 2 DIABETES. A DISTINGUISHABLE FEATURE OF TYPE 2 DIABETES BESIDES HYPERGLYCEMIA AND DERANGED LIPID PROFILE IS AN IMPAIRED INSULIN SECRETION, PERIPHERAL INSULIN RESISTANCE AND OBESITY WHICH HAS BECOME A MAJOR HEALTH CONCERN WORLDWIDE. INDIA WITH AN ESTIMATED 31MILLION DIABETICS IN 2000 AND 79MLLIONS BY THE YR 2030 HAS THE HIGHEST NUMBER OF TYPE 2 DIABETICS IN THE WORLD. IN THIS STUDY, WE AIMED TO SEE IF YOGA-ASANAS AND PRANAYAMAS HAVE ANY INFLUENCE IN MODIFYING CERTAIN BIOCHEMICAL PARAMETERS. SIXTY PATIENTS OF UNCOMPLICATED TYPE 2 DIABETES (AGE 35-60 YRS OF 1-10 YRS DURATION) WERE DIVIDED INTO TWO GROUPS: GROUP 1 (N=30): PERFORMED YOGA ALONG WITH THE CONVENTIONAL HYPOGLYCEMIC MEDICINES AND GROUP 2 (N=30): PATIENTS WHO ONLY RECEIVED CONVENTIONAL MEDICINES. DURATION OF THE STUDY WAS 45 DAYS. BASAL RECORDINGS OF BLOOD GLUCOSE (FASTING AND POST-PRANDIAL), LIPID PROFILE AND SERUM INSULIN WERE TAKEN AT THE TIME OF RECRUITMENT AND THE SECOND READING AFTER FORTY FIVE DAYS. RESULTS SHOWED A SIGNIFICANT IMPROVEMENT IN ALL THE BIOCHEMICAL PARAMETERS IN GROUP 1 WHILE GROUP 2 SHOWED SIGNIFICANT IMPROVEMENT IN ONLY FEW PARAMETERS, THUS SUGGESTING A BENEFICIAL EFFECT OF YOGA REGIMEN ON THESE PARAMETERS IN DIABETIC PATIENTS. 2008 14 497 30 COMBINED AYURVEDA AND YOGA PRACTICES FOR NEWLY DIAGNOSED TYPE 2 DIABETES MELLITUS: A CONTROLLED TRIAL. BACKGROUND: THE INCREASING PREVALENCE OF TYPE 2 DIABETES IN INDIA IS A CAUSE FOR NATIONAL CONCERN, PARTICULARLY THE SPIRALING COST BURDEN TO THE COUNTRY. AS ONE APPROACH TO STOP ITS INCREASE, YOGA MEDICINE HAS BEEN WIDELY IMPLEMENTED, FINDING POPULARITY WITH ALL SOCIAL STRATA. HERE, WE REPORT A STUDY SUGGESTING THAT TREATMENT WITH FRESH HERBAL JUICES AND YOGA CAN IMPROVE THE LEVELS OF BLOOD GLUCOSE AND HEMOGLOBIN A1C (HBA1C) IN PEOPLE WITH PRE-DIABETES. METHODS: STUDY DESIGN: 3-ARM CONTROLLED TRIAL 3 MONTHS IN DURATION. PARTICIPANTS: 157 MALE PRISONERS WITH NEWLY DIAGNOSED, HIGH FASTING BLOOD SUGAR (FBS) AND POSTPRANDIAL BLOOD SUGAR (PPBS) LEVELS. GROUP INTERVENTIONS: (1) RASAHARA AND YOGA, (2) YOGA, (3) NO INTERVENTION. ASSESSMENTS: FBS AND PPBS LEVELS WERE MEASURED EVERY 2 WEEKS; HBA1C AND BLOOD LIPIDS WERE DETERMINED PRE- AND POST-INTERVENTION. RESULTS: SIGNIFICANT DECREASES OCCURRED IN THE FBS (-21.13 +/- 21.16 MG/DL) AND PPBS LEVELS (-15.02 +/- 14.89 MG/DL) IN GROUP 1 (BOTH P < 0.0001) AND IN THE FBS LEVEL (20.62 +/- 32.68 MG/DL) IN GROUP 2 (P = 0.0005), WHILE THE INCREASES IN GROUP 3 ATTAINED SIGNIFICANCE ONLY FOR THE PPBS LEVEL (9.62 +/- 21.83 MG/DL) (P = 0.0022). OBSERVED CHANGES IN HBA1C WERE: GROUP 1, -0.044 +/- 0.059 MG/DL; GROUP 2, +0.024 +/- 0.456 MG/DL (NOT SIGNIFICANT); AND GROUP 3, +0.365 +/- 0.369 MG/DL (P < 0.0001). CONCLUSIONS: THIS STUDY OF YOGA FOR THE TREATMENT OF DIABETES SHOWS THAT ALL MALE PRISONERS COULD BENEFIT FROM THE YOGA PRISON PROGRAMS. ADDITION OF YOGA PROGRAMS TO STATE AND FEDERAL ACTIVITIES AT ALL LEVELS IS NOW NATIONAL POLICY IN INDIA. FOLLOW-UP STUDIES SHOULD BE CARRIED OUT TO OBTAIN MORE ROBUST RESULTS. 2018 15 887 15 EFFECT OF YOGA TYPE BREATHING ON HEART RATE AND CARDIAC AXIS OF NORMAL SUBJECTS. EFFECT OF INSPIRATORY AND EXPIRATORY PHASES OF NORMAL QUIET BREATHING, DEEP BREATHING AND SAVITRI PRANAYAM TYPE BREATHING ON HEART RATE AND MEAN VENTRICULAR QRS AXIS WAS INVESTIGATED IN YOUNG, HEALTHY UNTRAINED SUBJECTS. PRANAYAM TYPE BREATHING PRODUCED SIGNIFICANT CARDIOACCELERATION AND INCREASE IN QRS AXIS DURING THE INSPIRATORY PHASE AS COMPARED TO EUPNEA. ON THE OTHER HAND, EXPIRATORY EFFORT DURING PRANAYAM TYPE BREATHING DID NOT PRODUCE ANY SIGNIFICANT CHANGE IN HEART RATE OR QRS AXIS. THE CHANGES IN HEART RATE AND QRS AXIS DURING THE INSPIRATORY AND EXPIRATORY PHASES OF PRANAYAM TYPE BREATHING WERE SIMILAR TO THE CHANGES OBSERVED DURING THE CORRESPONDING PHASES OF DEEP BREATHING. 1986 16 1374 38 IMPACT OF AN INTEGRATED YOGA THERAPY PROTOCOL ON INSULIN RESISTANCE AND GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES MELLITUS. OBJECTIVE: DIABETES MELLITUS (DM), CHARACTERIZED BY CHRONIC HYPERGLYCEMIA, IS ATTRIBUTED TO RELATIVE INSULIN DEFICIENCY OR RESISTANCE, OR BOTH. STUDIES HAVE SHOWN THAT YOGA CAN MODULATE PARAMETERS OF INSULIN RESISTANCE. THE PRESENT STUDY EXPLORED THE POSSIBLE BENEFICIAL EFFECTS OF INTEGRATED YOGA THERAPY WITH REFERENCE TO GLYCEMIC CONTROL AND INSULIN RESISTANCE (IR) IN INDIVIDUALS WITH DIABETES MAINTAINED ON STANDARD ORAL MEDICAL CARE WITH YOGA THERAPY, COMPARED TO THOSE ON STANDARD ORAL MEDICAL CARE ALONE. METHODS: IN THIS STUDY, THE SUBJECTS ON YOGA INTERVENTION COMPRISED 35 TYPE 2 DIABETICS, AND AN EQUAL NUMBER OF VOLUNTEERS CONSTITUTED THE CONTROL GROUP. SUBJECTS RANGED IN AGE FROM 30 TO 70 YEARS, WITH HEMOGLOBIN A1C (HBA1C) TEST MORE THAN 7%, AND WERE MAINTAINED ON DIABETIC DIET AND ORAL HYPOGLYCEMIC AGENTS. BLOOD SAMPLES WERE DRAWN PRIOR TO AND AFTER 120 DAYS OF INTEGRATED YOGA THERAPY INTERVENTION. FASTING BLOOD GLUCOSE (FBG), POST-PRANDIAL BLOOD GLUCOSE (PPBG), HBA1C, INSULIN, AND LIPID PROFILE WERE ASSESSED IN BOTH THE INTERVENTION AND CONTROL GROUPS. RESULTS: THE INTERVENTION GROUP REVEALED SIGNIFICANT IMPROVEMENTS IN BODY MASS INDEX (BMI) (0.7 KG/M(2) MEDIAN DECREASE; P=0.001), FBG (20 MG/DL MEDIAN DECREASE; P<0.001), PPBG (33 MG/DL MEDIAN DECREASE; P<0.001), HBA1C (0.4% MEDIAN DECREASE; P<0.001), HOMEOSTATIC MODEL ASSESSMENT FOR INSULIN RESISTANCE (HOMA-IR) (1.2 MEDIAN DECREASE; P<0.001), CHOLESTEROL (13 MG/DL MEDIAN DECREASE, P=0.006), TRIACYLGLYCEROL (22 MG/DL MEDIAN DECREASE; P=0.027), LOW-DENSITY LIPOPROTEIN (6 MG/DL MEDIAN DECREASE; P=0.004), AND VERY-LOW-DENSITY LIPOPROTEIN LEVELS (4 MG/DL MEDIAN DECREASE; P=0.032). INCREASES IN HIGH-DENSITY LIPOPROTEIN AFTER 120 DAYS WERE NOT SIGNIFICANT (6 MG/DL MEDIAN INCREASE; P=0.15). HOWEVER, WHEN COMPARED TO CHANGES OBSERVED IN PATIENTS IN THE CONTROL GROUP, ALL THESE IMPROVEMENTS PROVED TO BE SIGNIFICANT. CONCLUSION: ADMINISTRATION OF INTEGRATED YOGA THERAPY TO INDIVIDUALS WITH DIABETES LEADS TO A SIGNIFICANT IMPROVEMENT IN GLYCEMIC CONTROL, INSULIN RESISTANCE, AND KEY BIOCHEMICAL PARAMETERS. 2022 17 2463 34 YOGA AS A THERAPEUTIC INTERVENTION FOR THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS. PURPOSE: THIS STUDY AIMED TO INVESTIGATE THE EFFECTS OF 12 WEEKS YOGIC INTERVENTION ON BLOOD SUGAR AND LIPID PROFILE IN ELDER WOMEN WITH TYPE 2 DIABETES MELLITUS (T2DM). SUBJECTS AND METHODS: TWENTY ELDERLY (AGE RANGE 55-70 YEARS) T2DM WOMEN WERE DIVIDED INTO TWO GROUPS, NAMELY, YOGIC INTERVENTION GROUP (YIG: N = 10, AGE 64.70 +/- 4.03, BODY MASS INDEX [BMI] 24.26 +/- 3.40) AND CONTROL GROUP (CG: N = 10, AGE 64.40 +/- 4.79, BMI 24.28 +/- 2.36). YIG UNDERWENT YOGA PRACTICE (ASANAS, KRIYAS, PRANAYAMAS) FOR 12 WEEKS (3 SESSIONS/WEEK), WHILE THE CG CONTINUED THEIR USUAL ROUTINE ACTIVITIES. STANDING HEIGHT, BODY WEIGHT, BMI, BLOOD SUGAR, AND LIPID PROFILE WERE MEASURED BEFORE COMMENCEMENT AND AFTER 6 AND 12 WEEKS OF YOGIC INTERVENTION IN BOTH GROUPS. RESULTS: THERE WAS A SIGNIFICANT (P < 0.01) DECREASE IN FASTING PLASMA GLUCOSE, POSTPRANDIAL BLOOD SUGAR, TOTAL CHOLESTEROL, TRIGLYCERIDES, LOW-DENSITY LIPOPROTEIN, AND VERY LOW DENSITY LIPOPROTEIN, WITH A SIGNIFICANT (P < 0.01) INCREASE IN HIGH-DENSITY LIPOPROTEIN LEVEL FROM ITS INITIAL VALUE IN YIG, WHILE SHOWING INSIGNIFICANT RESULT IN CG. CONCLUSION: IT CAN BE SAID THAT YOGIC INTERVENTION MAY HAVE THE BENEFICIAL EFFECTS ON BLOOD SUGAR AND LIPID PROFILE IN ELDERLY WOMEN WITH T2DM. 2018 18 2153 27 THE EFFECTS OF SUDARSHAN KRIYA YOGA ON SOME PHYSIOLOGICAL AND BIOCHEMICAL PARAMETERS IN MILD HYPERTENSIVE PATIENTS. AN OPEN LABEL INTERVENTION STUDY WAS UNDERTAKEN ON 26 MILD HYPERTENSIVES AND 26 APPARENTLY HEALTHY ADULTS (30-60 Y), FOR THE EFFECT OF SUDARSHAN KRIYA YOGA PRACTICE FOR TWO MONTHS AS COMPLEMENTARY THERAPY. IN THE HYPERTENSIVES, THERE WAS A SIGNIFICANT DECREASE IN DIASTOLIC BLOOD PRESSURE (P < 0.01), SERUM UREA (P < 0.01) AND PLASMA MDA (MALONDIALDEHYDE ADDUCTS) AS OXIDATIVE STRESS MARKER (P < 0.05). OTHER PARAMETERS; VIZ.; PLASMA LEVELS OF CHOLESTEROL, TRIGLYCERIDES, GLUCOSE, DID NOT CHANGE SIGNIFICANTLY (P > 0.1). THE PATTERN OF CHANGE IN MOST OF THE STUDY PARAMETERS WAS SUCH THAT VALUES ABOVE NORMAL RANGE WERE LOWERED BUT VALUES WITHIN NORMAL RANGE WERE UNALTERED. THE ACTION OF YOGA ON DIASTOLIC BLOOD PRESSURE, MALONDIALDEHYDE ADDUCTS AND KIDNEY FUNCTION IN HYPERTENSIVES WAS OF COUNTERACTIVE NATURE AND FELT TO BE DISTINCTLY DIFFERENT THAN THE EFFECT OF DRUGS. 2011 19 812 30 EFFECT OF YOGA ON CARDIAC AUTONOMIC DYSFUNCTION AND INSULIN RESISTANCE IN NON-DIABETIC OFFSPRING OF TYPE-2-DIABETES PARENTS: A RANDOMIZED CONTROLLED STUDY. OBJECTIVE: THE PRESENT STUDY WAS AIMED TO DETERMINE THE EFFECT OF YOGA PROGRAM ON CARDIAC AUTONOMIC DYSFUNCTION AND INSULIN RESISTANCE IN NON-DIABETIC OFFSPRING OF DIABETES PARENTS. METHODS: A RANDOMIZED PASSIVE-CONTROLLED STUDY WAS CONDUCTED ON 64 NON-DIABETIC OFFSPRING OF TYPE-2-DIABETES PARENTS (MEAN-AGE:25.17YEARS). YOGA GROUP PARTICIPANTS RECEIVED YOGA TRAINING FOR 8 WEEKS. HEART-RATE VARIABILITY (HRV) INDICES: LOW FREQUENCY (LF), HIGH FREQUENCY (HF) AND LF/HF RATIO; FASTING BLOOD GLUCOSE (FBG), ORAL GLUCOSE TOLERANCE TEST (OGTT) AND INSULIN RESISTANCE (IR) WERE ESTIMATED AT BASELINE AND AFTER 8-WEEKS OF INTERVENTION. RESULTS: WE FOUND A SIGNIFICANT DECREASE IN LF (P=0.005), LF/HF RATIO (P=0.004), IR (P<0.001), OGTT (P=0.003) AND INCREASE IN HF (P=0.022) IN YOGA GROUP PARTICIPANTS. CONTROL GROUP PARTICIPANTS DID NOT SHOW ANY SIGNIFICANT CHANGE IN ANY VARIABLES. CONCLUSIONS: IMPROVEMENT IN CARDIAC AUTONOMIC FUNCTION AND INSULIN RESISTANCE BY YOGA TRAINING IMPLIES THAT YOGA CAN REDUCE THE RISK OF DEVELOPMENT OF DIABETES IN OFFSPRING OF DIABETES PARENTS. 2019 20 1928 28 ROLE OF YOGA IN DIABETES. THE SCIENCE OF YOGA IS AN ANCIENT ONE. IT IS A RICH HERITAGE OF OUR CULTURE. SEVERAL OLDER BOOKS MAKE A MENTION OF THE USEFULNESS OF YOGA IN THE TREATMENT OF CERTAIN DISEASES AND PRESERVATION OF HEALTH IN NORMAL INDIVIDUALS. THE EFFECT OF YOGIC PRACTICES ON THE MANAGEMENT OF DIABETES HAS NOT BEEN INVESTIGATED WELL. WE CARRIED OUT WELL DESIGNED STUDIES IN NORMAL INDIVIDUALS AND THOSE WITH DIABETES TO ASSESS THE ROLE OF YOGIC PRACTICES ON GLYCAEMIC CONTROL, INSULIN KINETICS, BODY COMPOSITION EXERCISE TOLERANCE AND VARIOUS CO-MORBIDITIES LIKE HYPERTENSION AND DYSLIPIDEMIA. THESE STUDIES WERE BOTH SHORT TERM AND LONG-TERM. THESE STUDIES HAVE CONFIRMED THE USEFUL ROLE OF YOGA IN THE CONTROL OF DIABETES MELLITUS. FASTING AND POSTPRANDIAL BLOOD GLUCOSE LEVELS CAME DOWN SIGNIFICANTLY. GOOD GLYCAEMIC STATUS CAN BE MAINTAINED FOR LONG PERIODS OF TIME. THERE WAS A LOWERING OF DRUG REQUIREMENT AND THE INCIDENCE OF ACUTE COMPLICATIONS LIKE INFECTION AND KETOSIS WAS SIGNIFICANTLY REDUCED. THERE WERE SIGNIFICANT CHANGES IN THE INSULIN KINETICS AND THOSE OF COUNTER-REGULATORY HORMONES LIKE CORTISOL. THERE WAS A DECREASE IN FREE FATTY ACIDS. THERE WAS AN INCREASE IN LEAN BODY MASS AND DECREASE IN BODY FAT PERCENTAGE. THE NUMBER OF INSULIN RECEPTORS WAS ALSO INCREASED. THERE WAS AN IMPROVEMENT IN INSULIN SENSITIVITY AND DECLINE IN INSULIN RESISTANCE. ALL THESE SUGGEST THAT YOGIC PRACTICES HAVE A ROLE EVEN IN THE PREVENTION OF DIABETES. THERE IS A BENEFICIAL EFFECT ON THE CO-MORBID CONDITIONS LIKE HYPERTENSION AND DYSLIPIDEMIA. 2007